PCO

Immunoglobulin G Lambda Heavy And Light Chain Combined

Product code
PCO
Device name
Immunoglobulin G Lambda Heavy And Light Chain Combined
Device class
Class 2
21 CFR
21 CFR 866.5510
Medical specialty
Immunology
Marketing pathway
510(K)
Flag
Third-party review eligible

FDA classification definition

Intended for the in-vitro quantification of IgG lambda concentration in human serum. The result is to be used with previously diagnosed IgG multiple myeloma, in conjunction with other clinical and laboratory findings.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: PCO
Classification and pathway per current FDA publications. Data from openFDA (CC0).